会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Method of Diagnosing Pancreatic Cancer with the Use of N-Binding Type Sugar Chains
    • 使用N-结合型糖链诊断胰腺癌的方法
    • US20110065141A1
    • 2011-03-17
    • US12991340
    • 2009-05-08
    • Tokuzo AraoKazuko MatsumotoKazuto NishioHiroki SakamotoMasayuki KitanoMasatoshi Kudo
    • Tokuzo AraoKazuko MatsumotoKazuto NishioHiroki SakamotoMasayuki KitanoMasatoshi Kudo
    • C12Q1/37C12Q1/34
    • G01N33/57438Y10T436/24
    • The present invention is to provide a novel marker for diagnosing pancreatic cancer, a method for determining if a subject has pancreatic cancer utilizing the marker, etc. The present inventors collected blood from patients of 78 cases in total including patients of 24 cases with pancreaticobiliary-duct benign disorder (16 gallstone cases and 8 pancreatitis cases) and patients of 54 cases with pancreatic cancer, and mass spectrometry was performed on N-linked sugar chains in plasma. From the 74 mass-spectrometric peaks detected, 65 sugar chains were extracted based on the results of PAM analysis. These extracted sugar chains were then used to predict pancreatic cancer or pancreaticobiliary-duct benign disorder, to correctly diagnose 74% cases. Further, a T-test was performed between the two groups, the group of pancreaticobiliary-duct benign disorder and the group of pancreatic cancer, which identified two sugar chains, the sugar chain of m/z 3031 and the sugar chain of m/z 2362, as sugar chains demonstrating significant difference (p
    • 本发明提供一种用于诊断胰腺癌的新型标记物,用于确定受试者是否使用标记物的胰腺癌的方法等。本发明人从78例患者中收集了总共包括24例胰腺胆管癌患者的血液, 膀胱良性疾病(16例胆囊病例和8例胰腺炎病例)和54例胰腺癌患者,并对血浆中的N链糖链进行质谱分析。 根据PAM分析结果,从检测到的74个质谱峰中提取出65个糖链。 然后将这些提取的糖链用于预测胰腺癌或胰胆管良性疾病,以正确诊断74%的病例。 此外,在两组之间进行T检验,即胰胆管良性病变组和胰腺癌组,鉴定了两条糖链,m / z 3031的糖链和m / z的糖链 2362,由于糖链显示出显着性差异(p <0.05),并且两组之间的表达水平呈现2倍或更大的差异。 使用这些糖链的正确检测率用六个分类器计算,所有这些分类器都得到约70%的正确检测结果。
    • 4. 发明申请
    • Fluorescence detecting device
    • 荧光检测装置
    • US20080142730A1
    • 2008-06-19
    • US11979579
    • 2007-11-06
    • Masao MakiuchiKazuko Matsumoto
    • Masao MakiuchiKazuko Matsumoto
    • G01N21/64
    • G01N21/6408G01N21/645G01N21/6452G01N2021/6484
    • To provide a technology of increasing a sensitivity of detecting fluorescence. A fluorescence detecting device includes an excitation light source emitting excitation light that excites a fluorescence-marked measured object, a first optical path via which the excitation light impinges on the fluorescence-marked measured object, a detector detecting fluorescence emitted when the excitation light impinges on the fluorescence-marked measured object, a second optical path via which the fluorescence gets incident on the detector, and a chopper chopping the excitation light passing through the first optical path and the fluorescence passing through the second optical path, and thus controlling a relative relationship between a passage period of the excitation light and a passage period of the fluorescence.
    • 提供增加检测荧光的灵敏度的技术。 荧光检测装置包括:激发光源,其发射激发荧光标记测量对象的激发光;激发光照射在荧光标记的被测物体上的第一光路;检测器,其检测当激发光照射时发射的荧光 荧光标记测量对象,荧光入射到检测器上的第二光路,以及切割通过第一光路的激发光和通过第二光路的荧光的斩光器,从而控制相关关系 在激发光的通过期间和荧光的通过期间。
    • 5. 发明授权
    • Fluorescent group-containing carbodiimide compound
    • 含荧光素的碳二亚胺化合物
    • US5856479A
    • 1999-01-05
    • US857536
    • 1997-05-16
    • Osamu SuzukiGen MasudaNamiko ShiohataKazuko Matsumoto
    • Osamu SuzukiGen MasudaNamiko ShiohataKazuko Matsumoto
    • C07C267/00C07H21/00G01N33/58C12Q1/68
    • C07H21/00C07C267/00G01N33/582
    • Using the fluorescent group-containing carbodiimide compound represented-by the following formula (I) as the label and the like in the nucleic acid detection method, immunoassay, or chemiluminescence assay, labeling can be made efficiently for a short time, a nucleic acid derived from nature can be labelled, and highly sensitive assay is enabled.B--Y.sup.3 --N.dbd.C.dbd.N--Y.sup.2 --W--Y.sup.1 --�A!.sub.n --F(I)wherein F represents a fluorescent group;A represents a moiety selected from the group consisting of --CH.sub.2 --, --NHCO--, --CONH--, --O--, --S--, --NR-- wherein R is an alkyl group, --COO--, --OCO--, --NHSO.sub.2 --, and --SO.sub.2 NH--;n is 0 or 1;W represents a direct bond or a quaternary ammonium group;Y.sup.1, Y.sup.2 and Y.sup.3 each represents an alkylene group which may have a functional group in its main chain; andB represents H or a monovalent organic group which may be the same as or different from that represented by --W--Y.sup.1 --�A!.sub.n --F.
    • 在核酸检测方法,免疫测定或化学发光测定中使用由下式(I)表示的含荧光基的碳二亚胺化合物作为标记等,可以在短时间内有效地进行标记,得到的核酸 自然界可以进行标记,高灵敏度测定可用.B-Y3-N = C = N-Y2-W-Y1- [A] nF(I)其中F表示荧光基团; A表示选自-CH 2 - , - NHCO - , - CONH - , - O - , - S - , - NR-的基团,其中R是烷基,-COO - , - OCO-, - NHSO 2 - 和-SO 2 NH-; n为0或1; W表示直接键或季铵基; Y1,Y2和Y3各自表示在其主链中可具有官能团的亚烷基; B表示H或可以与-W-Y1- [A] n -F表示的相同或不同的一价有机基团。
    • 6. 发明申请
    • Novel method of highly sensitive nucleic acid analysis
    • 高灵敏度核酸分析的新方法
    • US20060029938A1
    • 2006-02-09
    • US10506240
    • 2003-03-10
    • Kazuko MatsumotoJingli Yuan
    • Kazuko MatsumotoJingli Yuan
    • C12Q1/68C07F5/00
    • C12Q1/6818C12Q1/6827C12Q2563/137C12Q2561/12C12Q2561/109
    • It is intended to provide a method of highly sensitively analyzing SNPs. More specifically, it is intended to provide an SNP analysis method whereby a large amount of SNPs can be quickly analyzed using a DNA sample in a trace amount. An SNP analysis method by the invader method with the use of a FRET probe having a luminescent dye and a quencher characterized by using, as the luminescent dye in the FRET probe, a rare earth fluorescent complex label made of a rare earth element such as europium or terbium. A composition for controlling fluorescent luminescence which comprises a combination of a specific rare earth fluorescent complex label with a specific fluorescent quencher. A highly sensitive labeling probe characterized by using a rare earth fluorescent complex label as a luminescent dye and a fluorescent quencher label as a quencher in a highly sensitive labeling probe such as a FRET probe and an SNP analysis kit containing the same.
    • 旨在提供高灵敏度分析SNP的方法。 更具体地,旨在提供一种SNP分析方法,其中可以使用微量的DNA样品快速分析大量的SNP。 通过使用具有发光染料和猝灭剂的FRET探针的入侵者方法的SNP分析方法,其特征在于使用FRET探针中的发光染料作为稀土元素如铕的稀土荧光复合体标记 或铽。 用于控制荧光发光的组合物,其包含特定稀土荧光复合物标记与特定荧光猝灭剂的组合。 特征在于使用稀土荧光复合体标记作为发光染料的高敏感性标记探针,以及在高灵敏度标记探针如FRET探针和含有该荧光标记的SNP分析试剂盒中使用荧光猝灭剂标记作为猝灭剂。
    • 7. 发明申请
    • Novel fluorescent label compounds
    • 新型荧光标记化合物
    • US20050255465A1
    • 2005-11-17
    • US10506242
    • 2003-03-10
    • Kazuko MatsumotoJingli YuanGuilan WangMingqian Tan
    • Kazuko MatsumotoJingli YuanGuilan WangMingqian Tan
    • C07D213/36C07D213/38C07D401/14C07D409/14C07D491/14C07D498/22C07F5/00C12Q1/68G01N33/533
    • C07D213/36C07D401/14G01N33/533
    • It is intended to provide novel labeling reagents characterized by having a group capable of binding to a substance to be labeled (for example, a biological substance, a physiologically active substance, etc.), easily forming a complex together with a rare earth ion, the complex being stable in an aqueous solution, and having a sufficient fluorescence intensity and a long fluorescence life time regardless of buffer types; complexes composed of the above labeling reagent with a rare earth ion; fluorescence labels containing the above complex; a fluorescence assay method using the above fluorescent label; etc. Namely, labeling reagents comprising a compound having a 2,2′:6′,2″-tripyridine skeleton or a 2,6-dipyrazolopyridine skeleton and having a group capable of binding to a substance to be labeled (for example, a biological substance, a physiologically active substance, etc.) and a group capable of forming a complex together with a rare earth ion; complexes composed of the above labeling reagent with a rare earth ion; fluorescence labels containing the above complex; a fluorescence labeling method using the above complex as a label; and a fluorescence assay method using the above fluorescent label.
    • 旨在提供新颖的标记试剂,其特征在于具有能够与待标记的物质结合的基团(例如生物物质,生理活性物质等),容易与稀土离子一起形成络合物, 该复合物在水溶液中稳定,并且具有足够的荧光强度和长的荧光寿命,而不管缓冲液类型如何; 由上述标记试剂与稀土离子组成的络合物; 含有上述复合物的荧光标记物; 使用上述荧光标记物的荧光检测方法; 即,包括具有2,2':6',2“ - 三吡啶骨架或2,6-二吡唑并吡啶骨架的化合物的标记试剂,并具有能够结合待标记的物质的基团(例如, 生物物质,生理活性物质等)和能够与稀土离子一起形成络合物的基团; 由上述标记试剂与稀土离子组成的络合物; 含有上述复合物的荧光标记物; 使用上述复合物作为标签的荧光标记方法; 和使用上述荧光标记物的荧光测定方法。
    • 8. 发明授权
    • Method for separating and collecting nucleic acids
    • 分离和收集核酸的方法
    • US06777181B2
    • 2004-08-17
    • US09771439
    • 2001-01-26
    • Kazuko Matsumoto
    • Kazuko Matsumoto
    • C12Q168
    • C12Q1/6806C12Q2537/157C12Q2565/501
    • A method for separating and collecting nucleic acids, which comprises: a step of bringing a sample nucleic acid solution into contact with a nucleic acid-immobilized substrate comprising a substrate and two or more kinds of single-stranded nucleic acids separately immobilized on the substrate, to allow hybridization of the immobilized single-stranded nucleic acids and single-stranded nucleic acids complementary to the immobilized single-stranded nucleic acids, and a step of separating the hybridized single-stranded nucleic acids according to immobilized portions of the immobilized nucleic acids, to collect the hybridized single-stranded nucleic acids without disassembling the nucleic acid-immobilized substrate.
    • 一种分离和收集核酸的方法,其包括:使样品核酸溶液与包含底物的核酸固定化底物和分别固定在所述底物上的两种或更多种单链核酸接触的步骤, 以允许固定化的单链核酸和与固定的单链核酸互补的单链核酸的杂交,以及根据固定的核酸的固定化部分分离杂交的单链核酸的步骤,以收集 杂交的单链核酸,而不拆分核酸固定的底物。
    • 9. 发明授权
    • High sensitivity immunoassay method
    • 高灵敏度免疫测定法
    • US07255998B1
    • 2007-08-14
    • US10089776
    • 2000-09-28
    • Kei TashiroTasuku HonjoMasaya IkegawaKazuko Matsumoto
    • Kei TashiroTasuku HonjoMasaya IkegawaKazuko Matsumoto
    • G01N33/53G01N33/532G01N33/533G01N33/24G01N21/76G01N33/547C07K1/10
    • G01N33/582G01N33/6863G01N2458/40Y10S435/968Y10S435/97Y10S435/975
    • A method for detecting a cytokine in a biological fluid sample with a high sensitivity is provided. A time-resolved fluoroimmunoassay (TR-FIA) method including a step of forming on a solid phase a composite in which a cytokine is captured and which includes a fluorescent structural portion which has been complexed with a lanthanoid metal ion, and measuring fluorescence of the fluorescent structural portion. The composite is formed of a structure in which (a) a first antibody including a portion bound to a solid phase and a region bindable to a cytokine; (b) the cytokine; (c) a second antibody including a region bindable to the cytokine and a portion to which biotin is bound; (d) a conjugate including streptoavidin or avidin and a fluorescent structural portion capable of being complexed with a lanthanoid metal ion; and (e) the lanthanoid metal ion are bound. The fluorescent structural portion is represented by General Formula (I): R—Ar—C(═O)—CH2—C(═O)—CnF2n—X.
    • 提供了一种以高灵敏度检测生物流体样品中的细胞因子的方法。 一种时间分辨荧光免疫测定(TR-FIA)方法,包括在固相上形成其中捕获细胞因子的复合物并包括与镧系元素金属离子络合的荧光结构部分的步骤,以及测量 荧光结构部分。 所述复合物由以下结构形成:其中(a)包含与固相结合的部分和与细胞因子结合的区域的第一抗体; (b)细胞因子; (c)包含与细胞因子结合的区域和生物素结合部分的第二抗体; (d)包含链霉亲和素或抗生物素蛋白的缀合物和能够与镧系金属离子络合的荧光结构部分; 和(e)镧系金属离子结合。 荧光结构部分由通式(I)表示:R-Ar-C(-O)-CH 2 -C(-O)-C N SUB> 2n -X。